Insulin glargine and lixisenatide and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
Determining the interaction of Insulin glargine and lixisenatide and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Omeclamox-Pak
- Insulin glargine and lixisenatide-Omega-3 Fatty Acid Capsules
- Insulin glargine and lixisenatide-Omega-3 Fatty Acids
- Insulin glargine and lixisenatide-Omega-3 polyunsaturated fatty acids
- Insulin glargine and lixisenatide-Omega-3-acid ethyl esters
- Insulin glargine and lixisenatide-Omega-3-carboxylic acids
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin glargine and lixisenatide Subcutaneous
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin glargine, recombinant Subcutaneous
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin glulisine
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin Glulisine (Cartridges and Pens)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin Glulisine (Vials)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Insulin glulisine Subcutaneous